Universe Pharmaceuticals (UPC) Competitors $3.85 +0.03 (+0.79%) Closing price 07/3/2025 03:17 PM EasternExtended Trading$3.81 -0.04 (-1.14%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock UPC vs. ATXI, SYRS, NCNA, BPTSY, VRPX, KRBP, MYMD, TCBP, CAPS, and VINCShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Avenue Therapeutics (ATXI), Syros Pharmaceuticals (SYRS), NuCana (NCNA), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), Kiromic BioPharma (KRBP), MyMD Pharmaceuticals (MYMD), TC Biopharm (TCBP), Capstone Therapeutics (CAPS), and Vincerx Pharma (VINC). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Its Competitors Avenue Therapeutics Syros Pharmaceuticals NuCana Biophytis Virpax Pharmaceuticals Kiromic BioPharma MyMD Pharmaceuticals TC Biopharm Capstone Therapeutics Vincerx Pharma Avenue Therapeutics (NASDAQ:ATXI) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations. Does the media refer more to ATXI or UPC? In the previous week, Avenue Therapeutics had 15 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 15 mentions for Avenue Therapeutics and 0 mentions for Universe Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.00 beat Avenue Therapeutics' score of -0.32 indicating that Universe Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Avenue Therapeutics Neutral Universe Pharmaceuticals Neutral Do institutionals and insiders have more ownership in ATXI or UPC? 17.3% of Avenue Therapeutics shares are held by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are held by institutional investors. 1.8% of Avenue Therapeutics shares are held by insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, ATXI or UPC? Avenue Therapeutics has a beta of -0.09, meaning that its share price is 109% less volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Is ATXI or UPC more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat Avenue Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Avenue TherapeuticsN/A -471.57% -296.50% Universe Pharmaceuticals N/A N/A N/A Which has better valuation and earnings, ATXI or UPC? Universe Pharmaceuticals has higher revenue and earnings than Avenue Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvenue TherapeuticsN/AN/A-$10.38M$18.350.02Universe Pharmaceuticals$23.02M0.01-$6.16MN/AN/A SummaryUniverse Pharmaceuticals beats Avenue Therapeutics on 7 of the 9 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$166K$790.73M$5.54B$20.72BDividend YieldN/A4.84%5.24%3.72%P/E RatioN/A1.3527.4328.09Price / Sales0.01226.97422.1138.30Price / CashN/A23.4436.8922.53Price / Book0.026.298.044.58Net Income-$6.16M-$27.73M$3.18B$986.06M7 Day Performance5.48%1.82%2.89%2.79%1 Month Performance-8.33%9.90%3.70%5.46%1 Year Performance-99.81%10.79%36.15%15.06% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$3.85+0.8%N/A-99.8%$166K$23.02M0.00220ATXIAvenue Therapeutics2.587 of 5 stars$0.20-16.5%N/A-90.0%$639KN/A0.014Trending NewsGap DownSYRSSyros Pharmaceuticals4.3589 of 5 stars$0.02-25.8%$3.33+14,915.0%-99.5%$596K$386K-0.01120Gap DownNCNANuCana2.5391 of 5 stars$0.06-33.2%$25.00+43,454.0%-98.0%$520KN/A-0.0130Gap DownHigh Trading VolumeBPTSYBiophytisN/A$1.38flatN/A-79.7%$484KN/A0.0030VRPXVirpax Pharmaceuticals1.3788 of 5 stars$0.32+0.3%$75.00+23,634.2%-97.1%$392KN/A0.007KRBPKiromic BioPharmaN/AN/AN/AN/A$330KN/A-0.0660Gap DownHigh Trading VolumeMYMDMyMD PharmaceuticalsN/A$0.13+3.6%N/A-93.4%$308KN/A0.006High Trading VolumeTCBPTC BiopharmN/A$0.68-55.8%$48.00+6,948.5%-99.5%$279K$4.76M0.0080High Trading VolumeCAPSCapstone TherapeuticsN/A$1.80+7.8%N/AN/A$260K$44.88M0.0038Gap UpHigh Trading VolumeVINCVincerx Pharma2.6439 of 5 stars$0.04-12.0%$40.00+90,809.1%-99.7%$230KN/A0.0060Gap Up Related Companies and Tools Related Companies ATXI Alternatives SYRS Alternatives NCNA Alternatives BPTSY Alternatives VRPX Alternatives KRBP Alternatives MYMD Alternatives TCBP Alternatives CAPS Alternatives VINC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UPC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
